Clinical Trial Update: MIDCAB Versus DES in Proximal LAD Lesions [NA]

View source ↗

Summary

A completed clinical trial from the University of Leipzig compared minimally invasive direct coronary artery bypass (MIDCAB) with drug-eluting stents (DES) for …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Drug-Eluting Stent (DES) (drug-eluting stent)
• MIDCAB (minimally invasive direct coronary artery bypass)

Snippet

Sponsor: University of Leipzig | Conditions: Coronary Artery Disease | NA | Status: COMPLETED